Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Cis-Mulberroside A

    • Product Name Cis-Mulberroside A
    • Alias Chebuloside II
    • Einecs NA
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    364991

    product_name Cis-Mulberroside A
    chemical_formula C35H42O19
    CAS_number 102841-42-9
    appearance White to off-white powder
    solubility Soluble in water and methanol
    purity Typically >98% (HPLC)
    storage_temperature 2-8°C
    source Extracted from Morus alba (Mulberry) root bark
    application Used in cosmetic, pharmaceutical, and biochemical research

    As an accredited Cis-Mulberroside A factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Cis-Mulberroside A is packaged in a sealed amber glass vial containing 10 mg, clearly labeled with product details and safety information.
    Shipping Cis-Mulberroside A is shipped in secure, leak-proof containers, protected from light and moisture. It is packed in accordance with chemical safety regulations, including proper labeling and documentation. Shipments are typically sent via express courier, ensuring temperature control if required, and delivered promptly to maintain compound integrity and quality.
    Storage Cis-Mulberroside A should be stored in a cool, dry place, typically at -20°C, and protected from light and moisture to maintain stability and prevent degradation. The compound should be kept in a tightly sealed container, away from incompatible substances. Avoid repeated freeze-thaw cycles and excessive exposure to air or humidity for optimal preservation of its chemical properties.
    Application of Cis-Mulberroside A

    Applications of Cis-Mulberroside A in Industrial Manufacturing

    Cis-Mulberroside A, a naturally occurring glycoside extracted from Morus alba root bark, finds established and emerging applications in various processing industries that require strict ingredient controls, proven bioactivity, and standardized performance. As a direct manufacturer, we support downstream partners with consistent grade quality and supply assurance for specialized applications. Below are the principal industrial application sectors with detailed integration parameters.

    1. Skin Whitening Agents for Cosmetic Formulations

    Cosmetic producers incorporate this material as a depigmenting and melanogenesis-inhibiting functional additive, notably within skin-whitening serums and creams. Our ingredient supplies formulation houses creating clinical-grade skin care products across Asia, Europe, and North America, where traceability, batch purity, and compliance with cosmetic directives strictly apply. Developers adjust ratio according to desired tyrosinase-inhibiting concentration and local market regulations, typically combining with other botanical actives. Ingredient is introduced at the emulsification or blending stage to maintain stability during subsequent product filling and packaging.

    Industry compliance standards

    • EU Cosmetics Regulation (EC) No 1223/2009
    • China National Medical Products Administration Cosmetic Standards
    • ISO 22716:2007 (Cosmetic GMP)
    • Japanese Standards of Quasi-drug Ingredients for Skincare

    Typical usage ratio

    • 0.01%–0.5% in finished skin serums and creams, titrated based on in vitro assay results and regulatory maximums

    Downstream process integration

    • Added post-emulsification, pre-cooling phase for stability; homogenized at 30–40°C to prevent glycoside degradation
    • QC sampling for HPLC assay in each batch prior to compounding

    Final product types

    • Whitening serums for facial application
    • Brightening daily creams
    • Pigment-correcting spot treatments
    • Dermocosmetic face masks

    2. Antioxidant Component in Functional Foods and Beverages

    Food manufacturers utilize this glycoside as a plant-sourced antioxidant for beverages, ready-to-eat powders, or high-value confectionery. Ingredient is integrated for its bioactive support of oxidative stability and to permit functional health food claims where allowed. Batch traceability, allergen controls, and food additive purity are critical in this segment. Dosing varies by national food additive lists and by matrix compatibility, often tested in pilot runs for heat stability and flavor neutrality, with ingredient added either prior to bottling (for beverages) or during final blending for dry products.

    Industry compliance standards

    • China GB 2760-2024 (National Food Safety Standard for Food Additives)
    • EU Regulation (EC) No 1333/2008 on Food Additives
    • US FDA GRAS determination, pending application status
    • FSSC 22000 and HACCP for process traceability and risk management

    Typical usage ratio

    • 0.02%–0.25% depending on application type, ingredient interaction, and intended health claim; modified based on antioxidant retention following heat process validation

    Downstream process integration

    • Dosage incorporated before final pasteurization for beverage lines
    • Blended with other microingredients during powder premix stage for solid foods
    • Inline QC sampling for glycoside retention post-processing

    Final product types

    • Functional beverage drinks and tonics
    • Antioxidant dietary powders
    • Enriched candies and gummies
    • Clean-label food supplements

    3. Botanical Ingredient in Traditional Chinese Medicine (TCM) Granules and Tablets

    Pharmaceutical-grade processors use this extract as an active plant marker compound in modern granule and film-coated tablet preparations that replicate classical herbal formulas for liver-protection or detoxification. GMP manufacturing controls and pharmacopoeial monograph compliance are strictly enforced. Ingredient usage aligns with granule dosage forms, with ratios standardized per pharmacology references and adjusted based on extraction yield in multi-herb blends. Integration steps include precise weighing, blending with excipients, and validation via quantitative HPLC testing before granulation and tableting.

    Industry compliance standards

    • Chinese Pharmacopoeia (current edition, Monograph for Morus alba)
    • China GMP (Good Manufacturing Practice for Pharmaceutical Products)
    • ISO 19610:2017 (Chinese Materia Medica — Good Agricultural and Collection Practices)
    • WHO Guidelines on Good Manufacturing Practices for Herbal Medicines

    Typical usage ratio

    • 0.2–2 mg per finished granule or tablet unit, calculated according to per-dose requirements in traditional formulas and standardized marker content

    Downstream process integration

    • Blended into powder bulk pre-granulation with other TCM actives
    • Content confirmed via HPLC standardized to reference standard
    • Granulation, drying, and tablet compression follow validated procedures

    Final product types

    • TCM granules for clinical dispensing
    • Film-coated herbal tablets
    • Integrated multi-herb capsules
    • Herbal extract sachets for hospital use

    4. Active Ingredient in Dermatological Prescription Preparations

    Pharmaceutical companies incorporate the glycoside as a validated tyrosinase inhibitor in prescription creams and ointments designed for post-inflammatory hyperpigmentation and melasma treatment. Formulations adhere to medical-grade standards with full documentation, impurity profiles, and batch traceability. Ratio determined through preclinical efficacy data and safety margins, adhering to monograph specifications. Ingredient addition occurs during active compounding with excipients under controlled temperature, with all raw material lots subject to batch-release analytical validation.

    Industry compliance standards

    • USP Monograph for Botanical Extracts (in relevant drug applications)
    • European Pharmacopoeia (Ph. Eur.) as applicable
    • ICH Q7 GMP for Active Pharmaceutical Ingredients
    • Medical Device Regulation (MDR) for applications in combination medical products (if relevant)

    Typical usage ratio

    • 0.05%–0.2% in prescription topical bases for medical application, titrated according to target inhibitory capacity and clinical data

    Downstream process integration

    • Precision dispensing during compounding with medical excipients
    • Analytical QC for actives content prior to filling into sterile or semi-sterile packaging
    • Batch sampling for stability and impurity profile analysis

    Final product types

    • Medical prescription creams
    • Dermatological ointments for hospital channel
    • Hospital-use topical solutions
    • Compounded customized preparations for clinics
    Free Quote

    Competitive Cis-Mulberroside A prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Cis-Mulberroside A: A Closer Look at Our Core Mulberry-Derived Product

    Harvesting Knowledge: From Morus Alba to Consistent Quality

    Decades have taught us the power of deep relationships with mulberry growers. The raw material for cis-Mulberroside A starts in the soil, shaped by weather patterns and farming practices. Not every batch of mulberry root bark meets the cut. Local suppliers know what drives purity, and year after year, that relationship yields our best starting material. We select Morus alba bark at precisely the right point in its growth cycle, avoiding over-aged material and immature roots. Our team inspects every shipment before extraction begins. These details lay the foundation for a consistent product.

    Refining the Art: Extraction and Purification without Compromise

    In the lab, experience counts. We set up extraction with nothing left to chance, controlling temperature, solvent ratios, and time to minimize breakdown of the cis-isomer during the process. Traditional hot water extractions may pull polysaccharides, but for cis-Mulberroside A, strict control over pH and gentle drying make all the difference. Too much heat or oxygen during concentration will trigger isomerization and diminish yield. Even veteran chemists keep a watchful eye on each batch, because slight variations in the crude powdered extract can foreshadow problems in the final chromatographic separation.

    Product Model and Specifications: Defining Our Standard

    Our laboratory grades cis-Mulberroside A under its HPLC peak purity, sourcing analytical reference material from independent standards bodies. In most batches designated as “Cis-Mulberroside A 98%,” the typical cis-isomer content exceeds 98% by HPLC, with total Mulberroside A (cis and trans isomers) sometimes slightly higher. Moisture, heavy metals, and solvent residue are monitored in every lot, because even minor contamination can affect sensitive downstream applications. Particle size depends on the customer’s needs, but for extraction labs and research institutions, a fine powder (<100 mesh) improves solubility, handling, and reproducibility in assays.

    The Value in Model Consistency

    Reproducibility in the lab comes down to lot-to-lot consistency. Pharmaceutical partners have stressed how trace impurity shifts can affect high-throughput screening or pilot studies. We keep records on all chromatographic profiles, giving customers access for regulatory filings and method development. For those in food science, monitoring plant polysaccharides and other non-active matrix compounds can make or break a formulation’s stability or mouthfeel. Our approach relies on routine skip-lot testing by independent third-party labs, not just in-house assays.

    Why Focus on the Cis-Isomer?

    Mulberroside A predominantly appears in two forms: cis and trans. Cis-Mulberroside A brings unique bioactivities. Pharmacologists have noted its advantages in studies of melanin synthesis, collagenase inhibition, and oxidative stress reduction. Recently, research in the cosmetic space has turned to cis-Mulberroside A for its depigmenting effects and skin barrier support. In our production, we separate the two forms, so the client can target specific research pathways. Trans isomer persists in some commercial extracts, but our process isolates and preserves the cis form with minimal cross-contamination, giving a sharper pharmacological profile for those requiring clarity of mechanism in their studies.

    Stability and Shelf-Life: Protecting Active Molecules

    Cis-isomers are notoriously sensitive — exposure to sunlight or high temperatures can quickly shift the equilibrium back toward the trans form, a process that undercuts active potency. We take cues from stability studies: every product batch moves from extraction through lyophilization with nitrogen blanketing to limit oxidation. Finished powder stores in amber, high-barrier packaging, not just simple plastic drums. Warehouse managers have learned over the years: ambient humidity and exposure to warehouse lights undo careful work at every step in the supply chain. We urge our clients to store product below 20°C, away from direct light; that keeps the isomer content stable for market inspection and downstream quality tests.

    Usage: Research, Formulation, and Beyond

    Cis-Mulberroside A’s uses have grown as researchers have peeled back its benefits. Labs in the pharmaceutical and cosmetic industries drive demand, but the stories behind these products begin with scientists pursuing mechanisms in pigment formation or inflammatory markers. Cis-Mulberroside A in topical formulas shows promise in reducing melanogenesis and supporting antioxidative skin defenses. In pharmaceuticals, efforts to link traditional Chinese medicine findings with modern endpoints create interest in combination formulas. Our product line supports both aqueous and non-aqueous formulations, but most R&D teams opt for the highly soluble powder in early discovery before moving to more complex delivery vehicles.

    Impact in the Pharmaceutical Sector

    Drug developers ask tough questions about purity windows, PCR product stability, and metabolite formation. We work directly with formulators to troubleshoot batch variability, often sharing HPLC and NMR data for verification. This transparency builds trust and accelerates preclinical work, especially where regulatory filings rest on lot traceability and process data. One formulation team recounts how even trace levels of trans-Mulberroside A in a cis-enriched fraction led to unpredictable skin-lightening outcomes. That feedback helped us refine our column protocols and could not have happened working solely through traders or intermediaries.

    Cosmetic Applications and Technical Challenges

    Cosmetic chemists value rapid dissolution and easy blending — yet, too much focus on powder fineness can create clumping or slow wetting. We adapted our milling and drying steps to avoid static and compaction, which often come up in bench-top trials. Compatibility with typical emollients, surfactants, and rest of the actives remains essential. Some major cosmetic clients put our lot-to-lot reproducibility to test in blinded formulation trials, with batches prepared months apart — feedback from those trials pointed to cumulative effects of small changes in pH or residual salts. We keep open lines to their analytical teams so tweaks in product specs quickly translate to cleaner, more consistent finished formulas.

    What Makes It Different from Other Mulberry Extracts?

    Many suppliers on the market deliver generic “mulberry root extract”, often with a blend of isomers and a fraction of active material. Bulk extracts can shift significantly in content depending on field, season, and extraction method. Some present as dark powders or viscous tars, much less suited for precision work. Our approach isolates and standardizes the cis-isomer, so scientists can layer results with confidence. Semi-quantitative supplier certificates from other factories prove insufficient for pharmaceutical cGMP programs or U.S. FDA submissions — our customers demand robust HPLC, MS, and NMR characterization, not just general saponin content. Removing off-tasting polysaccharide contaminants also helps in food applications. Finished products show visual uniformity — a key requirement for blending high-end skincare — and re-test after months shows only minor decline in cis content.

    Navigating Pricing Pressures and Quality Competition

    Every year, market pricing for mulberry-derived compounds fluctuates. We see cheaper, off-spec extracts enter the fray — typically with higher trans isomer and residual solvents from quick and dirty solvent extraction. Our sales team has visited clients burned by yellowed, foul-smelling powders that quickly failed in formulation trials under experimental stress tests. Our response relies on batch-level transparency. We invite audits, offer stability protocols for customer verification, and engage in joint troubleshooting to close the feedback loop between field and lab. Over time, that approach has built a loyal base in the specialty chemical space, for whom performance and trust trump the lowest price.

    Regulatory Support and Scientific Collaborations

    Navigating regulatory frameworks in different countries presents ongoing challenges. Our regulatory unit keeps close tabs on monograph changes in the Chinese, European, and U.S. Pharmacopeias. For clients preparing dossiers for import or registration, thorough documentation up front smooths the path. In project work, we team up with academic and clinical researchers to share spectral fingerprints, help design stability protocols, or ship analytical standards for proof-of-concept studies. Scientists have taken our sample packs to international symposia, reporting back on performance in high-throughput screens or clinical endpoints. We draw on their findings, adjusting our process controls with every round of published data, closing the loop between industrial practice and clinical inquiry.

    Analytical Capabilities and Lot Support

    Years spent troubleshooting failed lots have driven us to invest in state-of-the-art instrumentation. Our facility runs HPLC, LC-MS/MS, and FTIR protocols for every batch. Most customers request not only a typical COA, but full chromatograms for regulatory archives. We share that willingly, giving analytical chemists a detailed window into every batch’s fingerprint. Retention samples remain on claim for years, and we regularly participate in inter-laboratory proficiency testing to maintain unbiased standards. This open-book approach has won over R&D heavyweights who need confidence nature-identical character remains steady, even as weather, soil, and farming practice shift from year to year.

    Supporting Green Chemistry and Sustainable Sourcing

    Pressure mounts every season to adopt more sustainable processes. Water and solvent conservation form a core part of our daily routine — recycling spent solvents, treating wastewater, and investing in energy-efficient dryers have practical payback, both for the planet and our bottom line. Mulberry root bark harvesting has potential to drive excessive farmland use, but real-world relationships with local growers keep us honest. They report back on soil condition and harvesting rotation, making it possible to calibrate purchasing and avoid wasteful practices. We pilot new purification resins and solvents, aiming to minimize our chemical footprint. Sustainable sourcing shows up, too, in supplier certifications and quarterly audits at the field level, tracking chain of custody from shrub to drum.

    Customer Feedback: From the R&D Bench to the Plant Floor

    Direct lines of communication with scientists, formulators, and manufacturing teams let us field unique questions and chase down subtle issues. Some customers uncover quirks only at full production scale, reporting unexpected precipitation or color shift as they scale-up from pilot to commercial batch size. We encourage this feedback early, believing that real world surprises should return upstream, not sit as chronic pain points. Our team responds with practical advice — pre-dissolution protocols, pH adjustment, and filtration tips all grow out of this back-and-forth. In return, customers see better yield, less waste, and fewer post-purchase headaches.

    Challenges Ahead: Scaling Innovation without Sacrifice

    New demand for cis-Mulberroside A in global markets tests our ability to scale production without losing the careful controls honed over years. Training new team members presents the biggest hurdle — the hands and eyes involved in solvent handling, column loading, and fraction collection will always determine success. Investing in real-world skills and constant peer review guards against the drift seen as companies grow. At every stage, we choose methods that favor tight specification, robust documentation, and traceability back to the field. Mistakes can and do happen, but a culture of openness around failure and correction keeps production nimble and reliable.

    The Road Forward

    Cis-Mulberroside A occupies a special place in our catalog, not only as a high-value botanical product, but also as a touchstone for our company’s ethos. Our processes reflect years of learning, shaped by users who push the boundaries of research and formulation. Building long-term partnerships with clients, suppliers, and scientific collaborators remains the most important safeguard against quality drift and market volatility. As research grows in complexity, our main task stays the same: keeping standards sharp, documentation transparent, and lines open from the farm field to the customer’s formulation bench.